RxDoctor Payments Data

James Sills Powell

Foot & Ankle Surgery · Wentzville, MONPI 1689985087

Payments from drug & device makers

$6,633in general payments, 2019–2025

Across 95 payments — averaging $69.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Metric Medical Devices, Inc.$2K
  • Elite Orthopedics, LLC$1K
  • Organogenesis Inc.$645
  • Smith+Nephew$328
  • Zimmer Biomet$159
  • plus $253 from 9 others
$1,375in research payments, 2019–2025

Across 1 payment — averaging $1375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Metric Medical Devices, Inc.$1K

What the payments were for

  • Consulting fees$1,78827%
  • Food & beverage$1,54523%
  • Education$3,30050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,633 in reported general payments places this provider in the 55th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$181,579
Medicare patients
304
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.16$8,085
Mupirocin188$1,499
Ammonium Lactate33$991
Ketoconazole48$764
Ondansetron Hcl20$466
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$400
Ciclopirox14$320
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$304
Gabapentin26$234
Doxycycline Hyclate18$228
Cephalexin21$218
Ciprofloxacin Hcl11$79
Meloxicam12$29

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$328$8,08516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 163 foot & ankle surgery providers in Missouri.

Other foot & ankle surgery in Wentzville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →